Literature DB >> 19302556

Serum vascular endothelial growth factor in adult haematological patients with neutropenic fever: a comparison with C-reactive protein.

Sari Hämäläinen1, Auni Juutilainen, Irma Matinlauri, Taru Kuittinen, Esko Ruokonen, Irma Koivula, Esa Jantunen.   

Abstract

OBJECTIVES: Vascular endothelial growth factor (VEGF) is considered to be of importance in patients with sepsis. No data are available on VEGF kinetics in haematological patients with neutropenic fever.
METHODS: Forty-two haematological patients were included into this prospective study. Median age was 57 yr (range 18-70). Fifteen patients received therapy for acute myeloid leukaemia and 27 patients received autologous stem cell transplantation for haematological malignancy. Laboratory samples for the determination of C-reactive protein (CRP) and VEGF were collected at the start of fever (d0) and then daily.
RESULTS: The median serum VEGF concentrations were low in all study patients. In patients with severe sepsis (n = 5) the median VEGF on d0 was higher than in septic patients without signs of hypoperfusion or hypotension (n = 37) (77 pg/mL vs. 52 pg/mL, P = 0.061). Also on d1 the median VEGF concentration was higher in patients with severe sepsis (82 pg/mL vs. 56 pg/mL, P = 0.048). There were no statistically significant differences in CRP values on any day during the study period between patients with severe sepsis and those without. Time from d0 to the peak VEGF concentration (mean 1.02, SE 0.18 d) was shorter than that to the peak CRP concentration (mean 1.93, SE 0.15 d) (P = 0.002).
CONCLUSION: Compared to CRP, serum VEGF was a more rapid indicator for sepsis in our haematological patients with neutropenic fever. Those with severe sepsis had higher VEGF concentrations than those without on d0 and d1 after the onset of fever. Further studies on VEGF are warranted in haematological patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19302556     DOI: 10.1111/j.1600-0609.2009.01260.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  5 in total

1.  Time-course of sFlt-1 and VEGF-A release in neutropenic patients with sepsis and septic shock: a prospective study.

Authors:  Brunna E Alves; Silmara A L Montalvao; Francisco J P Aranha; Irene Lorand-Metze; Carmino A De Souza; Joyce M Annichino-Bizzacchi; Erich V De Paula
Journal:  J Transl Med       Date:  2011-03-03       Impact factor: 5.531

2.  C-reactive protein in critically ill cancer patients with sepsis: influence of neutropenia.

Authors:  Pedro Póvoa; Vicente Ces Souza-Dantas; Márcio Soares; JorgeI F Salluh
Journal:  Crit Care       Date:  2011-05-19       Impact factor: 9.097

3.  Soluble CD14 as a Diagnostic and Prognostic Biomarker in Hematological Patients with Febrile Neutropenia.

Authors:  Sini Korpelainen; Carina Intke; Sari Hämäläinen; Esa Jantunen; Auni Juutilainen; Kari Pulkki
Journal:  Dis Markers       Date:  2017-08-06       Impact factor: 3.434

4.  Novel Biomarker Candidates for Febrile Neutropenia in Hematological Patients Using Nontargeted Metabolomics.

Authors:  Marika Lappalainen; Jenna Jokkala; Auni Juutilainen; Sari Hämäläinen; Irma Koivula; Esa Jantunen; Kati Hanhineva; Kari Pulkki
Journal:  Dis Markers       Date:  2018-04-12       Impact factor: 3.434

5.  A high angiopoietin-2/angiopoietin-1 ratio is associated with a high risk of septic shock in patients with febrile neutropenia.

Authors:  Maiara Marx Luz Fiusa; Carolina Costa-Lima; Gleice Regina de Souza; Afonso Celso Vigorito; Francisco Jose Penteado Aranha; Irene Lorand-Metze; Joyce M Annichino-Bizzacchi; Carmino Antonio de Souza; Erich V De Paula
Journal:  Crit Care       Date:  2013-08-05       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.